News Column

Luye Pharma to List in Hong Kong

June 20, 2014

HONG KONG, June 20, SinoCast -- Mainland drug maker Luye Pharma will kick off road show on June 23, start IPO from June 26 and get listed in Hong Kong on July 9, financing at most CNY 6 billion, being the biggest drug stock in recent two years on local bourse.

30% financing has been locked up by cornerstone investors. Market cap will be CNY 20 billion and listing will be arranged by Citigroup and UBS.

Luye Pharma is engaged in research and development as well as production of natural drugs, new preparations and biotechnological products, whose 90% innovative drugs and preparations have independent intellectual property.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters